CSIMarket Company Name, Ticker, Industry, else..
 
The Oncology Institute Inc   (NASDAQ: TOI)
    Sector • Healthcare    Industry • Healthcare Facilities
   Industry • Healthcare Facilities
   Sector • Healthcare
 
Price: $6.2000 $6.20 %
Day's High: $6.53000020980835 Week Perf: 23.26 %
Day's Low: $ 6.09 30 Day Perf: -0.8 %
Volume (M): 1,782,268 52 Wk High: $ 7.05
Volume (M$): $ 0 52 Wk Avg: $3.85
Open: $6.23 52 Wk Low: $2.32



 Market Capitalization (Millions $) 631
 Shares Outstanding (Millions) 102
 Employees 641
 Revenues (TTM) (Millions $) 546
 Net Income (TTM) (Millions $) -33
 Cash Flow (TTM) (Millions $) -9
 Capital Exp. (TTM) (Millions $) 4

Business Description


The Oncology Institute Inc. is a medical organization specializing in oncology, or the diagnosis and treatment of cancer. Their primary focus is on providing comprehensive and personalized care to cancer patients. They offer a range of services including cancer screenings, diagnostic tests, radiation therapy, chemotherapy, immunotherapy, targeted therapy, and supportive care. The Oncology Institute Inc. has a team of highly trained and experienced oncologists, nurses, and other medical professionals who work together to provide the best possible care for their patients. They are dedicated to advancing cancer research, promoting education and awareness about cancer prevention and treatment, and improving the quality of life for cancer patients.


   Company Address: 18000 Studebaker Road, Suite 800 Cerritos 90703 CA
   Company Phone Number: 735-3226   Stock Exchange / Ticker: NASDAQ TOI


   

Stock Performances by Major Competitors

5 Days Decrease / Increase
     
AON   -10.47%    
BMY   -0.7%    
CAH        0.97% 
MCK        1.32% 
MRK   -1.92%    
PFE        1.75% 
• View Complete Report
   



Partnership

Revolutionizing Oncology Administration Touchless AI Automation Achieves Groundbreaking Efficiency Amidst Revenue Cha...

Published Fri, Nov 14 2025 9:56 AM UTC

In an era where efficiency and streamlined processes are more crucial than ever, Ascertain and The Oncology Institute have emerged as leaders in the integration of touchless AI automation for oncology administration. Their collaboration culminated in the rapid deployment of a cutting-edge prior authorization system, remarkably established in just eight weeks, which has led t...
Shares

The Oncology Institute Secures $16.5 Million Boost Amid Surge in Stakeholder Confidence and Industry Innovations,

Published Mon, Mar 24 2025 10:01 AM UTC

The Oncology Institute Paves the Way for Growth with $16.5 Million Private Placement Amid Changing Healthcare LandscapeThe Oncology Institute, Inc. (NASDAQ: TOI), recognized as one of the most extensive value-based community oncology groups in the United States, is marking a significant milestone in its growth trajectory with the announcement of a $16.5 million private place...
Product Service News

A New Era in Oncology Care Florida Blue’s Optimism Amidst Industry Challenges

Published Wed, Dec 18 2024 9:05 PM UTC

As cancer care remains a focal point in the American healthcare landscape, Florida Blue is making strides in enhancing oncology services for its members. Recently, the nonprofit health insurer announced a new initiative designed to improve patient outcomes, experiences, and overall quality of life by streamlining access to affordable and high-quality cancer care. This initia...
Management Changes

Jordan McInerney Joins The Oncology Institute as Chief Development Officer, Brings Expertise to Tackle Negative ROI and Propel Value-Based Specialty Care Models

Published Mon, Apr 8 2024 12:01 PM UTC


The Oncology Institute, Inc. has recently appointed Jordan McInerney as their Chief Development Officer. The move comes at a crucial time for the company, as it recorded a cumulative net loss of $-68 million during the 12 months ending in the fourth quarter of 2023. This has resulted in a negative return on investment (ROI) of -35.66%.
McInerney s appointment brings...
Partnership

Evolving Cancer Care: The Oncology Institute and Healthly Team Up to Extend Services Across Southern California

Published Thu, Apr 4 2024 12:00 PM UTC

CERRITOS, Calif., - April 04, 2024 The Oncology Institute, Inc. and its affiliates (NASDAQ: TOI) have chosen to join forces with Healthly, a burgeoning healthcare company, to redefine cancer care accessibility and experience for patients in Southern California. Healthly boasts over 180 primary care physicians, a comprehensive range of support services, and a core philosoph...



Fundamental Analysis

Valuation Current
Price to Earnings PE Ratio (TTM) 0.01
Price to Earnings PE Ratio (Expected) -
Price to Sales (TTM) 1.16
Price to Sales (Expected) -
Price to Book -
PEG (TTM) -

Financial Strength Current
Quick Ratio -
Working Capital Ratio 1.47
Leverage Ratio (MRQ) -
Total Debt to Equity -
Interest Coverage (TTM) -
Debt Coverage (TTM) -

Per Share Current
Earnings (TTM) 656.18 $
Revenues (TTM) 5.36 $
Cash Flow (TTM) -
Cash -
Book Value -
Dividend (TTM) 0 $

Efficiency Current
Revenue per Employee (TTM) 851,426
Net Income per Employee (TTM) -51,192
Receivable Turnover Ratio (TTM) 9.39
Inventory Turnover Ratio (TTM) 11.17
Asset Turnover Ratio (TTM) 3.33

Profitability Ratios Current
Gross Margin (MRQ) 63.79 %
Operating Margin (MRQ) -4.42 %
Net Margin (MRQ) -1.42 %
Net Cash Flow Margin (MRQ) -2.23 %
Effective Tax Rate (TTM) -

Management Effectiveness Current
Return On Assets (TTM) -
Return On Investment (TTM) -
Return On Equity (TTM) -
Dividend Yield -
Pay out Ratio (TTM) -



The Oncology Institute Inc's Segments
Patient services    40.08 % of total Revenue
Capitated revenue    18.27 % of total Revenue
FFS revenue    21.81 % of total Revenue
Specialty pharmacy revenue    59.37 % of total Revenue
Clinical research trials and other revenue    0.55 % of total Revenue
segments    100 % of total Revenue
Patient services segments    40.08 % of total Revenue
Specialty pharmacy segments    59.37 % of total Revenue
Clinical trials other segments    0.55 % of total Revenue

  The Oncology Institute Inc Outlook

On March 27 2024 the The Oncology Institute Inc provided following guidance

During the fourth quarter of 2023, The Oncology Institute Inc. (TOI) achieved strong financial results, showcasing its position as one of the leading value-based community oncology groups in the country. The company, listed on the NASDAQ under the ticker symbol TOI, reported its year-end financial results on March 27, 2024.

The Oncology Institute Inc. disclosed that it had generated impressive revenue figures for both the fourth quarter and the full year of 2023. The company's success can be attributed to its commitment to providing high-quality care to cancer patients while also adhering to value-based principles. TOI's financial performance underscores its dedication to delivering exceptional servic...





Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.